GlassScriptPhysician profile
Eva Babekov
NPI 1194960112
$1,166.11
in general payments reported to CMS, 2019-2025
17 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $118 · 2023: $167 · 2024: $379 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $247.54 | 2024-2025 | Repatha, Repatha, Otezla |
| Medtronic, INC. | $128.94 | 2021-2025 | Minimed 780g, Minimed 770g |
| Lilly USA, LLC | $107.86 | 2022-2025 | Mounjaro, Jardiance |
| Horizon Therapeutics Plc | $84.29 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $77.07 | 2024-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $72.96 | 2021 | |
| Astellas Pharma US INC | $71.05 | 2023 | Veozah, Myrbetriq |
| Corcept Therapeutics | $55.39 | 2024 | Korlym |
| Dexcom, INC. | $47.50 | 2021 | |
| Amarin Pharma, INC. | $44.08 | 2022 | |
| Insulet Corporation | $42.54 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $42.50 | 2023 | Uzedy |
| Merck Sharp & Dohme LLC | $36.28 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.84 | 2021-2024 | Xarelto |
| Abbvie INC. | $28.63 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $21.88 | 2024 | Perseris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.76 | 2024 | Jardiance, Synjardy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Babekov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.